Dan Yarosh

My advice to students: 
“Study the subjects you are most interested in because your job of the future has probably not been invented yet.”

Daniel B. Yarosh, PhD

is a technology advisor and expert on the convergence of science and business in skincare and dermatology.

His attention is now focused on the emerging sciences in skin care, such as DNA repair and the microbiome, and neuromarketing and evolutionary biology of beauty. He advises companies on applications of biotechnology and scouts for the latest technology that can impact the beauty and skincare industries. 

Dr. Yarosh serves on the Board of Directors, Aceto Corp. (Nasdaq: ACET) a NY pharma company, including the Audit & Risk as well as the Compensation Committee.
He retired from Estee Lauder Co. in 2016 after serving as Chief Technology Advisor.  From 2008 to 2014 he was Senior Vice President, Basic Science Research, Estee Lauder Co. and was responsible for their worldwide basic research. He supervised labs focused on biology, biochemistry, botanicals, physics, optics, imaging, skin physiology and clinical testing in 5 global sites. Basic science research includes internal projects, collaborations with vendors and support of university research through its extramural research program.  This provided the fuel for the continuous stream of innovative prestige beauty products for which the Estee Lauder brands (including Estee Lauder, Clinique, MAC, Origins and Crème de La Mer) are renowned. During his tenure, Estee Lauder launched hero iconic brand products that exceeded projections, overall sales grew ahead of competition, and the EL stock price tripled.

​Dr. Yarosh received his BA degree in Biology from Macalester College, St. Paul, Minnesota, in 1976, and his Doctorate in Molecular Biology from the University of Arizona College of Medicine in 1978. He served as a National Science Foundation Fellow at Brookhaven National Laboratory, Upton, New York, and then a Staff Fellow and Cancer Expert at the National Cancer Institute of the National Institutes of Health, Bethesda, Maryland.

In 1985, Dr. Yarosh founded the biotechnology
company AGI Dermatics, with an emphasis on the commercial application of DNA repair. He is the inventor of Dimericine (T4N5 liposome lotion), which is a liposomal DNA repair enzyme for the prevention of skin cancer.  AGI Dermatics also supplied ingredients to many major worldwide cosmetic and personal care companies.  In 2006 the company launched its own Remergent
® brand of skincare products, including sunscreens and prescription drugs.  In 2008, AGI Dermatics was acquired by the Estee Lauder Co. 

Dr. Yar
​​osh is the author of more than 100 scientific papers and two dozen patents.  He is a member of the American Academy of Dermatology, and has been an active participant in the global scientific and New York biotechnology communities.  In 2004, the International Union of Photobiology presented Dr. Yarosh with the Finsen Award, which is granted every four years at the International Congress for Photobiology for breakthrough research in the photobiology sciences.  In 2008 he was honored by the American Cancer Society, Nassau County, for his professional service.

His book The New Science of Perfect Skin, about skincare technology in the cosmetic marketplace, was published by Random House in May 2008.

​His most recent writings can be found on the pages of this site.